VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | The current frontline treatment strategy in multiple myeloma

Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC, discusses the current frontline treatment strategy for patients with multiple myeloma, highlighting the role of quadruplets and triplets. Dr Voorhees first comments on the importance of assessing patient eligibility for autologous stem cell transplantation (autoSCT), highlighting data from the DETERMINATION trial (NCT01208662). Following this, Dr Voorhees discusses the role of quadruplet therapies in transplant-eligible patients, as well as the role of triplet therapies in transplant-ineligible patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter